KKG Immunmonitoring Publikationsliste
|
|
- Claud Jacobs
- 8 years ago
- Views:
Transcription
1 Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kürschner T, Schulze A, Urban S, Krönke M, Abken H, Protzer U.: T cells redirected against Hepatitis-B-virus surface proteins eliminate infected hepatocytes. Gastroenterology 2008, 134: Bohne F, Protzer U.: Adoptive T-cell therapy as a therapeutic option in chronic viral hepatitis. J. Viral Hepatitis 2007, 14, Suppl 1: Brill, T.H., Kübler, H.R., Pohla, H., Buchner, A., Fend, F., Schuster, T., van Randenborgh, H., Paul, R., Kummer, T., Plank, C., Eisele, B., Breul, J., Hartung, R., Schendel, D.J., Gansbacher, B.: Therapeutic vaccination with an interleukin-2interferon-g-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial Hum.Gene. Ther. 20, 1-11 (2009) Brill, T.H.*, Kübler, H.R.*, von Randenborgh, H.*, Fend, F.*, Pohla, H.*, Breul, J.*, Hartung, R.*, Paul, R.*, Schendel, D.J., Gansbacher, B.*: Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial. J. Gene Med. 9 (7), (2007) Butterfield, L.H., Disis, M.L., Fox, B.A., Lee, P.P., Khleif, S.N, Thurin, M., Trinchieri, G., Wang, E., Wigginton, J., Chaussabel, D., Coukos, G., Dhodapkar, M., Hakansson, L., Janetzki, S., Kleen, T.O., Kirkwood, J.M., Maccalli, C., Maecker, H., Maio, M., Malyguine, A., Masucci, G., Palucka, A.K., Potter, D.M., Ribas, A., Rivoltini, L., Schendel, D., Seliger, B., Selvan, S., S.L.ingluff, C.L., Stroncek, D.F., Streicher, H., Wu, X.F., Zeskind, B., Zhao, Y.D., Zocca, M.B., Zwierzina, H., Marincola, F.M.: A systematic approach to biomarker discovery; Preamble to "the isbtc-fda taskforce on immunotherapy biomarkers" J. Transl. Med. 6, 81 (2008) Cornberg M, Protzer U, Dollinger M, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns M. Prophylaxis, diagnosis and therapy of Hepatitis-B-Virus-(HBV-)Infection: Upgrade of the german guideline. Z. Gastroenterologie 2007, 45: Cosma, A., Nagaraj, R., Staib, C., Diemer, C.*, Wopfner, F.*, Schätzl, H.*, Busch, D.H., Sutter, G., Goebel, F.D.*, Erfle, V.: Evaluation of modified Vaccinia Virus Ankara as an alternative vaccine against smallpox in chronically HIV Type 1-Infected individuals undergoing HAART. Aids Res. Hum.Retrov. 23, (2007) Ebelt, K., Babaryka, G., Frankenberger, B., Stief, C.G., Eisenmenger, W., Kirchner, T., Schendel, D.J., Noessner, E.: Prostate cancer lesions are surrounded by FOXP3(+), PD-1(+) and B7-H1(+)lymphocyte clusters Eur. J. Cancer 45 (9), (2009) Ebelt K, Babaryka G, Figel AM, Pohla H, Buchner A, Stief CG, Eisenmenger W, Kirchner T, Schendel DJ, Noessner E.: Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. Prostate Jan 1;68(1):1-10
2 Endl, J.*, Rosinger, S.*, Schwarz, B.*, Friedrich, S.-O.*, Rothe, G.*, Karges, W.*, Schlosser, M.*, Eiermann, T.*, Schendel, D.J., Boehm, B.O.*: Co-expression of CD25 and Ox40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55, (2006) Frankenberger, B., Noessner, E., Schendel, D.J.: Immune suppression in renal cell carcinoma. Semin. Cancer Biol. 17 (4), (2007) Frankenberger, B., Regn, S., Geiger, C., Noessner, E., Falk, C.S., Pohla, H.*, Javorovic, M., Silberzahn, T., Wilde, S., Buchner, A.*, Siebels, M.*, Oberneder, R.*, Willimsky, G.*, Pezzutto, A.*, Blankenstein, T.*, Schendel, D.J.: Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells. World J. Urol. 23; (2005) Frankenberger, B., Pohla, H. *, Noessner, E., Willimsky, G.*, Papier, B., Pezzutto, A.*, Kopp, J.*, Oberneder, R.*, Blankenstein, T.*, Schendel, D.J.: Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs. ( equally contributed) Clin. Cancer Res. 11; (2005) Geiger, C., Nossner, E., Frankenberger, B., Falk, C.S., Pohla, H., Schendel, D.J.: Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma J. Mol. Med. 87 (6), (2009) Gudbjartsson, D.F., Bjornsdottir, U.S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G.M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., Williams, C., Hui, J., Beilby, J., Warrington, N.M., James, A., Palmer, L.J., Koppelman, G.H., Heinzmann, A., Krueger, M., Boezen, H.M., Wheatley, A., Altmuller, J., Shin, H.D., Uh, S.T., Cheong, H.S., Jonsdottir, B., Gislason, D., Park, C.S., Rasmussen, L.M., Porsbjerg, C., Hansen, J.W., Backer, V., Werge, T., Janson, C., Jonsson, U.B., Ng, M.C.Y., Chan, J., So, W.Y., Ma, R., Shah, S.H., Granger, C.B., Quyyumi, A.A., Levey, A.I., Vaccarino, V., Reilly, M.P., Rader, D.J., Williams, M.J.A., van Rij, A.M., Jones, G.T., Trabetti, E., Malerba, G., Pignatti, P.F., Boner, A., Pescollderungg, L., Girelli, D., Olivieri, O., Martinelli, N., Ludviksson, B.R., Ludviksdottir, D., Eyjolfsson, G.I., Arnar, D., Thorgeirsson, G., Deichmann, K., Thompson, P.J., Wjst, M., Hall, I.P., Postma, D.S., Gislason, T., Gulcher, J., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., Stefansson, K.: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction Nat. Genet. 41 (3), (2009) Hartl, D.*, Griese, M.*, Nicolai, T.*, Zissel, G.*, Prell, C.*, Reinhardt, D.*, Schendel, D.J., Krauss- Etschmann, S.: A role for MCP-I/CCR2 in interstitial lung disease in children. Resp. Res., (2005) Hartl, D.*, Griese, M.*, Nicolai, T.*, Zissel, G.*, Prell, C.*, Konstantopoulos, N.*, Gruber, R.*, Reinhardt, D.*, Schendel, D.J., Krauss-Etschmann, S.*: Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J. Allergy Clin. Immunol. 115, (2005)
3 Hartl, D.*, Griese, M.*, Kappler, M.*, Zissel, G.*, Reinhardt, D.*, Rebhan, C.*, Schendel, D.J., Krauss- Etschmann, S.: Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117, (2006) Hartl, D.*, Koller, B., Mehlhorn, A.T.*, Reinhardt, D.*, Nicolai, T.*, Schendel, D.J., Griese, M.*, Krauss-Etschmann, S.: Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119 (5), (2007) Hoffmann, D., Seebach, J., Cosma, A., Goebel, F.D., Strimmer, K., Schätzl, H.M., Erfle, V.: Therapeutic vaccination reduces HIV protein sequence variability. FASEB Journal: 22(2), (2008) Javorovic M, Wilde S, Zobywalski A, Noessner E, Lennerz V, Wölfel T, Schendel DJ.: Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells J. Immunother. (1997) Jan;31(1): Javorovic, M., Pohla, H.*, Frankenberger, B., Wölfel, T.*, Schendel, D.J.: RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysis. Mol Ther. 12; (2005) Kastenmüller, W., Gasteiger, G., Stross, L., Busch, D.H., Drexler, I.: Mucosal Application of a Lyophilized Viral Vector Vaccine Confers Systemic and Protective Immunity toward Intracellular Pathogens J. Immunol. 182 (5), (2009) Kastenmüller, W., Gasteiger, G., Gronau, J.H., Baier, R., Ljapoci, R., Busch, D.H., Drexler, I.: Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J. Exp. Med. 204 (9), (2007) Krauss-Etschmann, S., Niedermaier, S., Beyer, J., Campoy, C., Escolano, V., Decsi, T., Jakobik, V., Schendel, D.J., Demmelmair, H., Heinrich, J., Koletzko, B.V.: Current use of room disinfectants and allergic symptoms at the age of 4 years J. Allergy Clin. Immunol. 123 (5), (2009) Krauss-Etschmann, S. Hartl, D., Rzehak, P., Heinrich, J., Shadid, R., Del Carmen Ramírez-Tortosa, M., Campoy, C, Pardillo, S., Schendel, D.J., Decsi, T., Demmelmair, H., Koletzko, B.V., Nutraceuticals for Healthier Life Study Group: Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J. Allergy Clin. Immun. 121 (2), (2008) Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jiménez M, Gil A, Rivero M, Veszprémi B, Decsi T, Koletzko BV.: Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. Am. J. Clin. Nutr. 85 (5), (2007)
4 Krauss-Etschmann, S., Hartl, D., Heinrich, J., Thaqi, A., Prell, C., Campoy, C.*, Molina, F.S.*, Hector, A.*, Decsi,T.*, Schendel, D.J., Koletzko, B.V.*: Association between levels of Toll-like receptors 2 and 4 and CD14 mrna and allergy in pregnant women and their offspring. Clin. Immunol. 118, (2006) Krönig, H., Hofer, K., Conrad, H., Guilaume, P., Muller, J., Schiemann, M., Lennerz, V., Cosma, A., Peschel, C., Busch, DH., Romero, P., Bernhard, H.: Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY- ESO-1 have potent anti-tumor activity Int. J. Cancer 125 (3), (2009) Kutscher, S., Dembek, C.J., Allgayer, S., Heltai, S., Stadlbauer, B., Biswas, P., Nozza, S., Tambussi, G., Bogner, J.R., Stellbrink, H.J., Goebel, F.D., Lusso, P., Tinelli, M., Poli, G., Erfle, V., Pohla, H., Malnati, M., Cosma, A.: The intracellular detection of MIP-1beta enhances the capacity to detect IFN- gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT AIDS. Res. Ther. 5, 22 (2008) Levin, A., Hayouka, Z., Helfer, M., Brack-Werner, R., Friedler, A., Loyter, A.: Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration PLoS ONE 4 (1), e4155 (2009) Mamani-Matsuda, M., Cosma, A., Weller, S., Faili, A., Staib, C., Garçon, L., Hermine, O., Adoue, D., Fieschi, C., Pers, J.O., Arakelyan, N., Varet, B., Sauvanet, A., Berger, A., Paye, F., Andrieu, J.M., Michel, M., Godeau, B., Buffet, P., Reynaud, C.A., Weill, J.C.: The human spleen is the main reservoir for life long memory B-cells. Blood: Mar 3; [Epub ahead of print] (2008) Markoullis, K., Bulian, D.; Hölzlwimmer, G.; Quintanilla-Martinez, L.; Heiliger, K.J.; Zitzelsberger, H.; Scherb, H.; Mysliwietz, J.; Uphoff, C.C.; Drexler, H.G.; Adler, T.; Busch, D.H.; Schmidt, J.; Mahabir, E.: Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny Transgenic Res 18 (1), (2009) Raffegerst, S.H.; Hoelzlwimmer, G.; Kunder, S.; Mysliwietz, J.; Quintanilla-Martinez, L.; Schendel, D.J.: Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice PLoS ONE 4 (12), e8539 (2009) Renström, J., Istvanffy, R., Gauthier, K., Shimono, A., Mages, J., Jardon-Alvarez, A., Kröger, M., Schiemann, M., Busch, D.H., Esposito, I., Lang, R., Peschel, C., Oostendorp, R.A.: Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells Cell Stem Cell 5 (2), (2009) Rothenaigner, I., Kramer, S., Meggendorfer, M., Rethwilm, A.*, Brack-Werner, R.: Transduction of human neural progenitor cells with foamy virus vectors for differentiationdependent gene expression. Gene Ther. Doi: /gt (2008)
5 Rüttinger D, van den Engel NK, Winter H, Schlemmer M, Pohla H, Grützner S, Wagner B, Schendel DJ, Fox BA, Jauch KW, Hatz RA.: Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC : first clinical experience and evidence of an immune response. J. Transl. Med. 5:43, 1-14 (2007) Rüttinger, D.*, Winter, H.*, van den Engel, N.K.*, Hatz, R.A.*, Schlemmer, M.*, Pohla, H.*, Grützner, S.*, Schendel, D.J., Fox, B.A.*, Jauch, K.-W.*: Immunotherapy of lung cancer: an update. Onkologie 29; (2006) Scheich, F.*, Duyster, J.*, Peschel, C.*, Bernhard, H.: The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens. Blood 110 (7), (2007) Schendel, D.J.: Dendritic cell vaccine strategies for renal cell carcinoma. Opin. Biol.Ther. 7 (2), (2007) Schleypen, J.S., Baur, N., Kammerer, R.*, Nelson, P.J.*, Rohrmann, K.*, Gröne, E.F.*, Hohenfellner, M.*, Haferkamp, A.*, Pohla, H.*, Schendel, D.J., Falk, C.S., Noessner, E.: Cytotoxic markers and frequencies predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin. Cancer Res. 12; (2006) Schlosser, E.*, Mueller, M.*, Fischer, S.*, Basta, S.*, Busch, D.H., Gander, B.*, Groettrup, M.*: TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26 (13), (2008) Schuster IG, Busch DH, Eppinger E, Kremmer E, Milosevic S, Hennard C, Kuttler C, Ellwart JW, Frankenberger B, Nössner E, Salat C, Bogner C, Borkhardt A, Kolb HJ, Krackhardt AM.: Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 110, (2007) Shadid, R., Haarman, M.*, Knol, J.*, Theis, W.*, Beermann, C.*, Rjosk-Dendorfer, D.*, Schendel, D.J., Koletzko, B.V.*, Krauss-Etschmann, S.: Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-a randomized, doubleblind, placebo-controlled study. Am. J. Clin. Nutr. 86 (5), (2007) Stemberger, C., Neuenhahn, M., Gebhardt, F.E., Schiemann, M., Buchholz, V.R., Busch, D.H.: Stem cell-like plasticity of naive and distinct memory CD8(+) T cell subsets Semin. Immunol. 21 (2), (2009) Stemberger, C.*, Huster, K.M., Koffler, M.*, Anderl, F.*, Schiemann, M.*, Wagner, H., Busch, D.H.: A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets.: Immunity 27 (6), (2007) Stemberger, C.*, Neuenhahn, M.*, Buchholz, V.R.*, Busch, D.H.: Origin of CD8+ Effector and Memory T Cell Subsets. Cell. Mol. Immunol. 4 (6), (2007)
6 Wilde, S.; Sommermeyer, D.; Frankenberger, B.; Schiemann, M.; Milosevic, S.; Spranger, S.; Pohla, H.; Uckert, W.; Busch, D.H.; Schendel, D.J.: Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity Blood 114 (10), (2009) Zobywalski, A., Javorovic, M., Frankenberger, B., Pohla, H.*, Kremmer, E., Bigalke, I., Schendel, D.J.: Generation of clinical grade dendritic cells with capacity to produce biologically active IL- 12p70. Biomed Central / J. Transl. Medicine 5:18, 1-16 (2007)
The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor
The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer
More informationOncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder
Oncos Therapeutics: Personalized Cancer Immunotherapy ONCOS THERAPEUTICS Personalized Cancer Immunotherapy March 2015 Antti Vuolanto, COO and co-founder 1 History of Oncos Therapeutics 2002 2007 2009 Research
More informationspecific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression
More informationT Cell Maturation,Activation and Differentiation
T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-
More informationDendritic Cells: A Basic Review *last updated May 2003
*last updated May 2003 Prepared by: Eric Wieder, PhD MD Anderson Cancer Center Houston, TX USA What is a dendritic cell? Dendritic cells are antigen-presenting cells (APCs) which play a critical role in
More informationPredictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University
Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Changing Paradigms in Cancer Treatment Potential Uses of Biomarkers Adverse event
More informationAsthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System
1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID
More informationNEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds
NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.
More informationActivation and effector functions of HMI
Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ
More informationChapter 43: The Immune System
Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2
More informationBVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium
Dendritic cells : from bench to bedside BVIG/SBMI Meeting 2007 Bart N. Lambrecht, MD, PhD Department of Respiratory Diseases University Hospital Gent, Belgium Outline Role of DCs in the immune system Role
More informationChimeric Antigen Receptor T Cell Therapy
Chimeric Antigen Receptor T Cell Therapy Yi Lin, MD, PhD Mayo Clinic, Rochester, MN Alliance Spring Group Meeting - May 13, 2016 Presentation Objectives l Scientific overview of chimeric antigen receptor
More informationPresenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose
Presenter Disclosure: Renier J. Brentjens, MD, PhD Nothing to disclose Adoptive Therapy of Cancer with T cells Genetically Targeted to Tumor Associated Antigens through the Introduction of Chimeric Antigen
More informationImmunotherapy Concept Turned Reality
Authored by: Jennifer Dolan Fox, PhD VirtualScopics Inc. jennifer_fox@virtualscopics.com +1 585 249 6231 Immunotherapy Concept Turned Reality Introduction While using the body s own immune system as a
More informationName (print) Name (signature) Period. (Total 30 points)
AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,
More informationThe role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015
The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response
More informationIdentification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1
9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany
More informationImmunology and immunotherapy in allergic disease
Immunology and immunotherapy in allergic disease Jing Shen, MD Faculty Advisor: Matthew Ryan, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation February 2005
More informationImmune Checkpoint Blockade in Acute Myeloid Leukemia. Kinsey McCormick Hematology Fellow s Conference January 10, 2014
Immune Checkpoint Blockade in Acute Myeloid Leukemia Kinsey McCormick Hematology Fellow s Conference January 10, 2014 Overview Overview of immune checkpoints Immune checkpoints as mechanism of immune evasion
More informationMicrobiology AN INTRODUCTION EIGHTH EDITION
TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein
More informationCD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy
CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,
More informationIdentification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans
Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans Schwaiger Julia Clinical Institute of Virology 29.06.2009 1 Thank you! Franz X.
More informationOverview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development
Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites
More informationNew developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer
New developments in antigen-specific immunotherapies Novel therapeutic vaccines offer hope in the fight against chronic infectious disease and cancer Vaccination has been used effectively for more than
More informationModelling and analysis of T-cell epitope screening data.
Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,
More informationB Cells and Antibodies
B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production
More information2) Macrophages function to engulf and present antigen to other immune cells.
Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components
More informationThe Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationImmune Therapy for Pancreatic Cancer
Immune Therapy for Pancreatic Cancer December 16, 2014 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only:
More informationProspects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS
Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates
More informationMULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist
MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.
More information2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders
UPDATE ECIL-4 2011 2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders Jan Styczynski, Hermann Einsele, Rafael de la Camara, Catherine Cordonnier,
More informationThe Four Pillars of Cancer Therapy
Improving the Overall Understanding of Immunotherapy in Multiple Myeloma Webinar 2, August 19, 2015 Myeloma Vaccines: A New Use of a Time-Tested Treatment The Four Pillars of Cancer Therapy Surgery Radiation
More informationThis presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking
Q1/2016 This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking statements involve risks and uncertainties
More informationΔΕΝΤΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΚΑΙ ΕΜΒΟΛΙΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ DENDRITIC CELLS AND CANCER VACCINES
ΔΕΝΤΡΙΤΙΚΑ ΚΥΤΤΑΡΑ ΚΑΙ ΕΜΒΟΛΙΑ ΓΙΑ ΤΟΝ ΚΑΡΚΙΝΟ DENDRITIC CELLS AND CANCER VACCINES David Hunt. Cell Systems Initiative, U. of Washington. Βαίος Καρανίκας EU Marie Curie Fellow Μοναδα Ανοσολογίας Καρκίνου
More informationA Genetic Analysis of Rheumatoid Arthritis
A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.
More informationCancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important
More informationSupplemental Material CBE Life Sciences Education. Su et al.
Supplemental Material CBE Life Sciences Education Su et al. APPENDIX Human Body's Immune System Test This test consists of 31 questions, with only 1 answer to be selected for each question. Please select
More informationCytoreductive Therapy for Autologous Cell Therapy in HIV
Cytoreductive Therapy for Autologous Cell Therapy in HIV Ronald Mitsuyasu, MD Professor of Medicine UCLA Center for Clinical AIDS Research and Education (CARE Center) HSC Transfer from CCR5-delta 32 Donor
More informationEngineered T cells. Function (growth factor / effector cytokine / effector molecules) Trafficking chemokine receptors
Cell Processing Related Issues: Adoptive T cell Immunotherapy Bernard A. Fox Lab of Molecular and Tumor Immunology Robert W. Franz Cancer Research Center Providence Cancer Center Earle A. Chiles Research
More informationT Cell Immunotherapy for Cancer
T Cell Immunotherapy for Cancer Chimeric Antigen Receptors Targeting Tag-72 Glycoprotein for Colorectal Cancer Mitchell H. Finer Ph.D Genetix Pharmaceuticals Inc Work Completed at Cell Genesys Inc T Cell
More informationThe use of monoclonal antibodies in the setting of HSCT
The use of monoclonal antibodies in the setting of HSCT S Montoto, Barts Cancer Institute, London, UK Geneva 3/April/2012 www.ebmt.org Some definitions of interest: Ab and Ag Antibody (Ab)=Immunoglobulin
More informationB Cell Generation, Activation & Differentiation. B cell maturation
B Cell Generation, Activation & Differentiation Naïve B cells- have not encountered Ag. Have IgM and IgD on cell surface : have same binding VDJ regions but different constant region leaves bone marrow
More informationBioinformatics for cancer immunology and immunotherapy
Bioinformatics for cancer immunology and immunotherapy Zlatko Trajanoski Biocenter, Division for Bioinformatics Innsbruck Medical University Innrain 80, 6020 Innsbruck, Austria Email: zlatko.trajanoski@i-med.ac.at
More informationTransgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Statistically significant difference in progression-free survival continues to be seen in non-squamous
More informationB cell activation and Humoral Immunity
B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins.
More informationPulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic
Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells
More informationFetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant. Recipients
Fetal Maternal Immunity and Antileukemia Activity in Cord Blood Transplant Recipients Filippo Milano, 1 J. Lee Nelson, 1, 2 Colleen Delaney 1,3 1 Clinical Research Division, Fred Hutchinson Cancer Research
More informationOverview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
More informationHUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13
SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,
More informationAntibody Function & Structure
Antibody Function & Structure Specifically bind to antigens in both the recognition phase (cellular receptors) and during the effector phase (synthesis and secretion) of humoral immunity Serology: the
More informationBottle-neck Problems of Current Human Cancer Therapy
International Conference on Human Cell, Tissue-based Products and Tissue Banks, Oct. 13-14,Taipei, Taiwan Autologous Dendritic Cell-based Immunotherapy of Glioblastoma Multiforme: Post-Phase-I Clinical
More informationHow To Learn More About Melanoma
PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard
More informationThe Costimulatory Molecule CD27 Maintains Clonally
Immunity, Volume 35 Supplemental Information The Costimulatory Molecule CD7 Maintains Clonally Diverse CD8 + T Cell Responses of Low Antigen Affinity to Protect against Viral Variants Klaas P.J.M. van
More informationMaking the switch to a safer CAR-T cell therapy
Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction
More informationAdvances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope
Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope Daniel H. Sterman, M.D. Associate Professor of Medicine and Surgery Co-Director, PENN Mesothelioma and Pleural Program University
More informationBioMmune Technologies Inc. Corporate Presentation 2015
BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical
More informationThe Body s Defenses CHAPTER 24
CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,
More informationCombining Immunotherapy and Targeted Therapy in Melanoma
Combining Immunotherapy and Targeted Therapy in Melanoma 8:45 am - 9:15 am Antoni Ribas, M.D., h.d. rofessor of Medicine rofessor of Surgery rofessor of Molecular and Medical harmacology Director, Tumor
More informationEU Media Inquiries: Satu Kaarina Glawe Phone: +49 (0) 2638 947 9218 Mobile: +49 (172) 294 6264 Email: sglawe@its.jnj.com
EU Media Inquiries: Satu Kaarina Glawe Phone: +49 (0) 2638 947 9218 Mobile: +49 (172) 294 6264 Email: sglawe@its.jnj.com Investor Relations: Stan Panasewicz Phone: +1 732-524-2524 Louise Mehrotra Phone:
More informationHepatitis C Vaccines: Are we making progress?
Hepatitis C Vaccines: Are we making progress? Second International Hepatitis Cure and Eradication Meeting. Vancouver November, 2015 Objectives: Review the need for a preventive vaccine in 2015. Identify
More informationCIRM Webinar: CAR-T Cell Immunotherapy - Challenges and Opportunities Using Mature or Stem Memory T Cells, March 18th, 2015 Margo R Roberts, Ph.D.
CIRM Webinar: CAR-T Cell Immunotherapy - Challenges and Opportunities Using Mature or Stem Memory T Cells, March 18th, 2015 Margo R Roberts, Ph.D. Forward Looking Statements / Safe Harbor To the extent
More informationA white paper for consideration by the NIAID Microbial Sequencing Program
Hepatitis C Virus Sequencing: Viral evolution, immune recognition and vaccine development. A white paper for consideration by the NIAID Microbial Sequencing Program Todd M. Allen, Ph.D. Assistant Professor
More informationIdentification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES PKS Chan 陳 基 湘 S Ma 文 子 光 SM Ngai 倪 世 明 Key Messages 1. Subjects recovered from SARS-CoV infection retain memory of cellular immune response to epitopes
More informationMultiple Myeloma and Colorectal Cancer
Multiple Myeloma and Colorectal Cancer From Systems Immunology to Single Cells Leo Hansmann Mark M. Davis Lab Department of Microbiology&Immunology Stanford University Multiple Myeloma Monoclonal disease
More informationLESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES
Introduction to immunology. LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Today we will get to know: The antibodies How antibodies are produced, their classes and their maturation processes Antigen recognition
More informationGene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
More informationNatalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia
Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425
More informationMouse IFN-gamma ELISpot Kit
Page 1 of 8 Mouse IFN-gamma ELISpot Kit Without Plates With Plates With Sterile Plates Quantity Catalog Nos. 862.031.001 862.031.001P 862.031.001S 1 x 96 tests 862.031.005 862.031.005P 862.031.005S 5 x
More informationHapten - a small molecule that is antigenic but not (by itself) immunogenic.
Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationAutoimmunity and immunemediated. FOCiS. Lecture outline
1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic
More informationTEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.
TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS. The nomenclature of cytokines partly reflects their first-described function and also the order of their discovery. There is no single unified nomenclature,
More informationRheumatoid arthritis: an overview. Christine Pham MD
Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching
More informationVictims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
More informationEnhancing Anti-Tumor Activity of Checkpoint Inhibition
Enhancing Anti-Tumor Activity of Checkpoint Inhibition Jeffrey Schlom, Ph.D. Laboratory of Tumor Immunology and Biology (LTIB) Center for Cancer Research National Cancer Institute, NIH Laboratory of Tumor
More informationDecision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationAn Introduction to Stem Cell Biology. Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University
An Introduction to Stem Cell Biology Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University Figures adapted from ISSCR. Presentations of Drs. Martin Pera (Monash University),
More informationSTEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
More informationDisclosures. I have no disclosures.
Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer
More informationShantaram S. Joshi, Ph.D.
Shantaram S. Joshi, Ph.D. Functional Genomics of Leukemia Dendritic Cell Based Therapy for Cancer Dept. of Genetics, Cell Biology and Anatomy University of Nebraska Medical Center Omaha, Nebraska 68198-6395
More informationOne of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:
Immune system. One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: (pathogen - disease causing organism) 1) Non specific. Anything foreign
More informationHuman CD4+T Cell Care Manual
Human CD4+T Cell Care Manual INSTRUCTION MANUAL ZBM0067.02 SHIPPING CONDITIONS Human CD4+T Cells, cryopreserved Cryopreserved human CD4+T cells are shipped on dry ice and should be stored in liquid nitrogen
More informationDrug Development Services
Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through
More informationGuidance for Industry
Guidance for Industry Interpreting Sameness of Monoclonal Antibody Products Under the Orphan Drug Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationVitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model
Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC
More informationImmunovaccine Inc. (TSX-V: IMV)
May 2014 Immunovaccine Inc. (TSX-V: IMV) Targeted T cell Activation Immunotherapies FORWARD-LOOKING STATEMENTS This document contains forward-looking information pursuant to applicable securities law.
More information1 DNA Vaccines An Overview
1 1 DNA Vaccines An Overview Britta Wahren and Margaret Liu 1.1 Rationale for DNA Vaccines Administration of genes via DNA or RNA may be considered the next-generation of scientific development following
More informationAbout B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification
More informationSYNERGISTIC ROLE OF IL-15 IN THE EPITHELIUM AND THE LAMINA PROPRIA IN CELIAC DISEASE PATHOGENESIS
SYNERGISTIC ROLE OF IL-15 IN THE EPITHELIUM AND THE LAMINA PROPRIA IN CELIAC DISEASE PATHOGENESIS Bana Jabri Department of Medicine Celiac Disease Center University of Chicago Ingested gluten Environmental
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Evaluation of Medicines for Human Use London, 10 October 2007 Doc. Ref. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON POTENCY TESTING OF CELL BASED IMMUNOTHERAPY
More informationBADO meeting. Immunotherapy. in Metastatic Melanoma
BADO meeting Immunotherapy in Metastatic Melanoma UCL Université catholique de Louvain Prof J-Fr. BAURAIN Medical Oncology Department BADO Meeting Inaugural Lecture 07 december 2013 Melanoma Treatment
More information10 th EADO Congress Vilnius, 7-10 May 2014. Ipilimumab update. Michele Maio
10 th EADO Congress Vilnius, 7-10 May 2014 Ipilimumab update Michele Maio Medical Oncology and Immunotherapy, Department of Oncology University Hospital of Siena, Istituto Toscano Tumori SIENA, ITALY Evolving
More informationUnderstanding the Immune System in Myeloma
Brian GM Durie Understanding the Immune System in Myeloma Living Well with Myeloma Teleconference Series Thursday, March 19 th 2015 1 The Immune System is Like a Swiss Watch B Cell T Cell Plasma Cell Changing
More informationCorporate Presentation June 2, 2015
Corporate Presentation June 2, 2015 SAFE HARBOR STATEMENT This presentation contains forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationTABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.
x TABLE OF CONTENT ACKNOWLEDGEMENTS ENGLISH ABSTRACT THAI ABSTRACT LIST OF TABLES LIST OF FIGURES ABBREVIATIONS iii iv vii xv xvi xviii CHAPTER I: INTRODUCTION 1.1 Statement of problems 1 1.2 Literature
More information